SLXN

Header iconSLXN Comparison
Open Charts SLXNBanner chart's image
Silexion Therapeutics
Price$7.74
Change+$0.48 (+6.61%)
Volume$300
Capitalization5.66M
SLXN Comparison Chart in %
Loading...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Moderna (NASDAQ:MRNA), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 1.84B. The market cap for tickers in the group ranges from 58 to 100.52B. VRTX holds the highest valuation in this group at 100.52B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 2%. For the same Industry, the average monthly price growth was 20%, and the average quarterly price growth was 30%. JBPHF experienced the highest price growth at 194%, while OTLK experienced the biggest fall at -55%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -31%. For the same stocks of the Industry, the average monthly volume growth was -20% and the average quarterly volume growth was 37%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 100
Price Growth Rating: 57
SMR Rating: 100
Profit Risk Rating: 94
Seasonality Score: -15 (-100 ... +100)
Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (SLXN: $7.74)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLXN’s FA Score shows that 0 FA rating(s) are green while.

  • SLXN’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLXN’s TA Score shows that 5 TA indicator(s) are bullish.

  • SLXN’s TA Score: 5 bullish, 3 bearish.

Price Growth

SLXN (@Biotechnology) experienced а +13.75% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.11%. For the same industry, the average monthly price growth was +20.33%, and the average quarterly price growth was +29.99%.

Industries' Descriptions

@Biotechnology (+2.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLXN
Capitalization5.66M
EBITDA-17.81M
Gain YTD-74.345
P/E RatioN/A
Revenue0
Total Cash3.47M
Total Debt3.7M
TECHNICAL ANALYSIS
Technical Analysis
SLXN
RSI
ODDS (%)
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
10%
Momentum
ODDS (%)
Bullish Trend 1 day ago
27%
MACD
ODDS (%)
Bullish Trend 1 day ago
30%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
27%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
52%
Advances
ODDS (%)
Bullish Trend 1 day ago
53%
Declines
ODDS (%)
Bearish Trend 8 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
38%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Interact to see
Advertisement
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLPI47.980.03
+0.06%
Gaming and Leisure Properties
BALY10.00-0.09
-0.89%
Bally's Corporation
FBNC54.52-0.78
-1.41%
First Bancorp
UGRO0.42-0.01
-2.43%
urban-gro
GOCO5.09-0.22
-4.06%
GoHealth

SLXN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
+6.54%
IMA - SLXN
63%
Loosely correlated
-1.32%
CELC - SLXN
50%
Loosely correlated
+9.29%
MRSN - SLXN
43%
Loosely correlated
+0.39%
CHRS - SLXN
26%
Poorly correlated
+3.51%
QSI - SLXN
25%
Poorly correlated
-0.86%
More